[ Price : $8.95]
Federal Register Notice: FDA has determined the regulatory review period for Novartis Coartem (artemether/lumefantrine) is 285 day...[ Price : $8.95]
FDA cites as misleading a Watson Pharmaceuticals public bathroom promo that was used to promote Gelnique (oxybutynin chloride).[ Price : $8.95]
Consulting editor John Scharmann reviews the FDA leaderships increasing lack of transparency and suggests it may be a political co...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period set for Sanofi-Aventis Multaq for the purpose of patent exten...[ Price : $8.95]
Federal Register Notice: FDA makes available a guidance on the open public hearing at agency advisory committee meetings.[ Price : $8.95]
Federal Register Notice: FDAs Tobacco Products Scientific Advisory Committee will meet 1/10-11/11 to receive updates.[ Price : $8.95]
Sanuwave Health submits to FDA the first module of a PMA for its dermaPACE device for treating diabetic foot ulcers.[ Price : $8.95]
FDA posts a Teva Pharmaceuticals shortage of amikacin injection and a discontinuation of Hospiras Pontocaine HCl injection on its ...